Epidemiologi calcharacteristics of novel coronavirus pneumonia overview of COVID-19

ZHAO Tianming; XUAN Kun; LIU Haixia; CHEN Xin; SUN Yehuan

doi:10.19837/j.cnki.ahyf.2020.01.011

PDF(1303 KB)

Anhui Journal of Preventive Medicine ›› 2020, Vol. 26 ›› Issue (1) : 38-41. DOI: 10.19837/j.cnki.ahyf.2020.01.011

Epidemiologi calcharacteristics of novel coronavirus pneumonia overview of COVID-19

ZHAO Tianming¹, XUAN Kun¹, LIU Haixia¹, CHEN Xin¹, SUN Yehuan^1,2

Author information +

History +

Abstract

Corona Virus Disease 2019 (COVID-19) was discovered for the first time due to unexplained viral pneumonia cases in Wuhan in 2019 and was officially named by the World Health Organization on February 11, 2020. With the report of the first confirmed case in Tibet on January 29, 2020, COVID-19 infection had covered all provinces, autonomous regions, municipalities, Hong Kong and Macau special administrative regions, including Taiwan Province. Confirmed cases had also appeared in other countries. In order to strengthen the understanding of the epidemiological characteristics of COVID-19, this article reviewed the published relevant literature, combined with information published by relevant Chinese government departments and the World Health Organization, to summarize the epidemiological characteristics and preventive measures of COVID-19.

Key words

Novel coronavirus / Epidemiology / COVID-19

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

ZHAO Tianming, XUAN Kun, LIU Haixia, CHEN Xin, SUN Yehuan. Epidemiologi calcharacteristics of novel coronavirus pneumonia overview of COVID-19[J]. Anhui Journal of Preventive Medicine. 2020, 26(1): 38-41 https://doi.org/10.19837/j.cnki.ahyf.2020.01.011

References

[1] Hui D,Azhar E, Madani T, et al.The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China[J].Int J Infect Dis,2020,91:264-266.
[2] 魏秋华,任哲.2019新型冠状病毒感染的肺炎疫源地消毒措施[J/OL].中国消毒学杂志,2020(01):1-4[2020-02-10].
[3] 国家卫生健康委关于新型冠状病毒肺炎暂命名事宜的通知[EB/OL].(2020-02-08)[2020-02-09].http://www.nhc.gov.cn/xcs/yqfkdt/202002/18c1bb43965a4492907957875de02ae7.shtml.
[4] Li Q, Guan X, Wu P, et al.Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia[J].N Engl J Med.2020 Jan 29.doi: 10.1056/NEJMoa2001316.[Epub ahead of print].
[5] Huang C, Wang Y, Li X, et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J].Lancet.2020 Jan 24.pii: S0140-6736(20)30183-5.doi: 10.1016/S0140-6736(20)30183-5.[Epub ahead of print].
[6] 关于印发新型冠状病毒感染的肺炎诊疗方案(试行第五版)的通知[EB/OL].(2020-02-05)[2020-02-09].http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml.
[7] Zhu N, Zhang D, Wang W, et al.A novel coronavirus from patients with pneumonia in China, 2019[J].N Engl J Med.2020 Jan 24.doi: 10.1056/NEJMoa2001017.[Epub ahead of print].
[8] Wang W, Tang J, Wei F.Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China[J].J Med Virol,2020 Jan 29.doi: 10.1002/jmv.25689.[Epub ahead of print].
[9] Xu X,Chen P,Wang J,et al.Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission[J].Sci China Life Sci, 2020 Jan 21.doi: 10.1007/s11427-020-1637-5.[Epub ahead of print].
[10] Ji W, Wang W, Zhao X, et al.Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross‐species transmission from snake to human[J].J Med Virol.2020 Jan 22.doi: 10.1002/jmv.25682.[Epub ahead of print].
[11] Zhou P, Yang X, Wang X, et al.Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential batorigin[J].bioRxiv,2020:2020-2021.(Preprint version, January 23,2020.).
[12] 王卫国,胡姮,宋璐,等.不典型新型冠状病毒(2019-nCoV)感染的肺炎的影像学表现及诊断: 14例分析[J].医学新知, 2020, 30(1): 7-9.
[13] 靳英辉,蔡林,程真顺,等.新型冠状病毒(2019-nCoV)感染的肺炎诊疗快速建议指南(标准版)[J/OL].解放军医学杂志:1-20[2020-02-10].
[14] Guan W, Ni Z, Hu Y, et al., Clinical characteristics of 2019 novel coronavirus infection in China[J].medRxiv,2020.(Preprint version, February9, 2020.).
[15] Stop the Wuhan virus[J].Nature, 2020, 577: 450.
[16] Benvenuto D, Giovannetti M, Ciccozzi A, et al.The 2019-new coronavirus epidemic: evidence for virus evolution[J].J Med Virol, 2020 Jan 29.doi: 10.1002/jmv.25688.[Epub ahead of print].
[17] 王楷宬,李阳,庄青叶,等.禽源冠状病毒监测简报[J/OL].中国动物检疫:1-2[2020-02-10].
[18] Zhang H, Kang Z, Gong H, et al.The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes[J].bioRxiv,2020.(Preprint version, January31, 2020.).
[19] 中华人民共和国国家卫生健康委员会公告[EB/OL].(2020-01-20)[2020-02-10].http://www.nhc.gov.cn/xcs/zhengcwj/202001/44a3b8245e8049d2837a4f27529cd386.shtml.
[20] 欧阳芬,吴荷玉,杨英,等.基于武汉新型冠状病毒肺炎快速传播的应对措施[J/OL].全科护理:1-2[2020-02-10].
[21] Macintyre C, Chughtai A.Facemasks for the prevention of infection in healthcare and community settings[J].BMJ, 2015, 350:h694.
[22] Chan J, Kok K, Zhu Z, et al.Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan[J].Emerging Microbes Infect, 2020, 9(1): 221-236.
[23] Holshue M, DeBolt C, Lindquist S, et al.First Case of 2019 Novel Coronavirus in the United States[J].N Engl J Med.2020 Jan 31.doi: 10.1056/NEJMoa2001191.[Epub ahead of print].
[24] Yue X, Shao X, Li R, et al., Risk Management Analysis for Novel Coronavirus in Wuhan, China[J].J Risk Financial Manag, 2020, 13(2):22.
[25] Yu F, Du L, Ojcius D, et al.Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China[J].Microbes Infect.2020 Feb 1.pii: S1286-4579(20)30025-3.doi: 10.1016/j.micinf.2020.01.003.[Epub ahead of print].